- Home
- ISPC vs XXII Comparison
ISPC vs XXII Comparison
Compare ISPC & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPC
- XXII
- Stock Information
- Founded
- ISPC 2009
- XXII 1998
- Country
- ISPC United States
- XXII United States
- Employees
- ISPC N/A
- XXII N/A
- Industry
- ISPC Precision Instruments
- XXII Medicinal Chemicals and Botanical Products
- Sector
- ISPC Health Care
- XXII Health Care
- Exchange
- ISPC Nasdaq
- XXII Nasdaq
- Market Cap
- ISPC 6.9M
- XXII 6.2M
- IPO Year
- ISPC 2021
- XXII N/A
- Fundamental
- Price
- ISPC $0.86
- XXII $1.51
- Analyst Decision
- ISPC
- XXII
- Analyst Count
- ISPC 0
- XXII 0
- Target Price
- ISPC N/A
- XXII N/A
- AVG Volume (30 Days)
- ISPC 594.2K
- XXII 341.7K
- Earning Date
- ISPC 11-14-2025
- XXII 11-04-2025
- Dividend Yield
- ISPC N/A
- XXII N/A
- EPS Growth
- ISPC N/A
- XXII N/A
- EPS
- ISPC N/A
- XXII N/A
- Revenue
- ISPC $5,908,088.00
- XXII $21,362,000.00
- Revenue This Year
- ISPC $35.93
- XXII N/A
- Revenue Next Year
- ISPC N/A
- XXII $126.57
- P/E Ratio
- ISPC N/A
- XXII N/A
- Revenue Growth
- ISPC N/A
- XXII N/A
- 52 Week Low
- ISPC $0.64
- XXII $1.43
- 52 Week High
- ISPC $5.48
- XXII $394.02
- Technical
- Relative Strength Index (RSI)
- ISPC 44.70
- XXII 43.57
- Support Level
- ISPC $0.72
- XXII $1.43
- Resistance Level
- ISPC $0.91
- XXII $1.62
- Average True Range (ATR)
- ISPC 0.08
- XXII 0.08
- MACD
- ISPC 0.00
- XXII 0.02
- Stochastic Oscillator
- ISPC 49.46
- XXII 42.11
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.